The present invention is to provide a novel compound (I-1) shown below, having the anti-virus activity, particularly the HIV integrase inhibitory activity, and a drug containing the same, particularly an anti-HIV drug, as well as a process and an intermediate thereof.whereinA ring is substituted ring of (a), (b) or (c)wherein Z is O or NR19,R19 is hydrogen, C1-10alkyl, C2-8alkenyl, C1-10alkylcarbonyl or C1-10alkylsulfonyl, and the other substituents on the A ring form a ring；R14 and RX are hydrogen；a broken line represents the presence or absence of a bond, provided that when the broken line represents the presence of a bond, RX is not present；R1 is hydrogen or C1-10alkyl；X is C1-6alkylene；R2 is phenyl or phenyl substituted with at least halogen；R3 is hydrogen, halogen, hydroxy, C1-10alkyl, C2-8alkenyl, C1-10alkoxy, C2-8alkenyloxy or amino；or a pharmaceutically acceptable salt, or solvate thereof.
